Xenetic Biosciences
XBIO
6 hedge funds and large institutions have $1.41M invested in Xenetic Biosciences in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
86% more capital invested
Capital invested by funds: $758K → $1.41M (+$649K)
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$21.2K |
| 2 |
Morgan Stanley
New York
|
+$2.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.63K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.32M | – | – | – |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $41K | +$21.2K | +83 | New |
|
|
PAM
3
Panagora Asset Management
Boston,
Massachusetts
| $25K | -$4.86K | -19 | -27% |
|
|
4
Morgan Stanley
New York
| $13K | +$2.3K | +9 | +53% |
|
|
RE
5
RBC Europe
London,
United Kingdom
| $5.19K | – | – | – |
|
|
OIA
6
OneDigital Investment Advisors
Overland Park,
Kansas
| $2K | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$25K | -97 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$5.63K | -22 | Closed |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5K | -20 | Closed |
|
XBIO Hedge Fund Activity: Q2 2018 in Review
6 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q2 2018, worth a combined $1.41M — up 86% from $758K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of XBIO and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $21.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $25K sold.
- 6 institutional investors held Xenetic Biosciences (XBIO) as of Q2 2018, down from 8 in Q1 2018.
- Funds reported $1.41M of Xenetic Biosciences stock for Q2 2018, up 86% quarter-over-quarter.
- 1 fund opened new Xenetic Biosciences positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest Xenetic Biosciences buyer in Q2 2018 was Bank of Montreal, an estimated $21.2K added.
- The largest Xenetic Biosciences seller in Q2 2018 was Citadel Advisors, an estimated $25K sold.
Based on aggregated 13F filings for Q2 2018.